Related Experiment Video
Updated: Jun 14, 2026
09:38
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Cytokines, platelet production and hemostasis.
1Room 271 College of Health Building, University of Oklahoma Health Sciences Center, P.O. Box 26901, Oklahoma City, OK, 73190, USA.
Platelets
|March 20, 2010
Summary
Hematopoietic growth factors and cytokines impact platelet production and bleeding risk. Understanding these cytokine roles is crucial for treating bleeding disorders and preventing thrombosis.
Area of Science:
- Hematology
- Immunology
- Vascular Biology
Background:
- Hematopoietic growth factors and cytokines influence platelet production and function.
- These factors can be leveraged to manage bleeding tendencies in thrombocytopenic individuals.
- Conversely, cytokines can negatively impact hemostasis, potentially contributing to thrombosis and atherosclerosis.
Purpose of the Study:
- To explore the dual role of cytokines in platelet regulation and hemostasis.
- To investigate the potential therapeutic benefits of modulating cytokine activity for bleeding disorders.
- To assess the utility of cytokine inhibition in understanding thrombotic and atherogenic processes.
Main Methods:
- Review of existing literature on cytokine effects on hematopoiesis and hemostasis.
- Analysis of clinical implications for thrombocytopenia and bleeding disorders.
- Discussion of experimental approaches using cytokine inhibition.
Main Results:
- Cytokines demonstrate a significant capacity to modulate platelet production and function.
- Therapeutic enhancement of certain cytokines may reduce bleeding risks.
- Cytokine-induced prothrombotic and proatherogenic effects are recognized.
- Cytokine inhibition serves as a valuable tool for pathophysiological research.
Conclusions:
- Cytokines possess a complex role in platelet biology and hemostasis.
- Targeting cytokines offers potential therapeutic strategies for bleeding disorders.
- Inhibiting specific cytokines is a key method for studying their involvement in thrombogenesis and atherogenesis.
Related Concept Videos
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.